Back to Search
Start Over
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
- Source :
- Cell Research; April 2022, Vol. 32 Issue: 4 p404-406, 3p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 10010602 and 17487838
- Volume :
- 32
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Cell Research
- Publication Type :
- Periodical
- Accession number :
- ejs58789155
- Full Text :
- https://doi.org/10.1038/s41422-022-00617-x